A Vancomycin Order That Does Not Match the Patient or the Pump
Mr. B is 68 years old, 52 kg and 157 cm, admitted with MRSA bacteremia. His serum creatinine has been stable at 1.8 mg/dL, and an estimated creatinine clearance is 28 mL/min. The prescriber orders vancomycin 1,500 mg IV every 12 hours, infused over 60 minutes. Pharmacy delivers 1,500 mg in 250 mL of 0.9% sodium chloride. A vancomycin level drawn before this order was 28 mcg/mL, and he has received no vancomycin since that level. The first dose is due now, and the pump is already programmed at 250 mL/hr by the previous nurse. Mr. B mentions that his last hospital stay 'made my ears ring.'
1. Verify the infusion rate and concentration. Is the programmed rate acceptable, and what should it be?
Read the worked answer
Check the arithmetic first. 1,500 mg in 250 mL over 60 minutes = 250 mL/hr = about 4.2 mL/min = 25 mg/min. Concentration is 1,500 mg / 250 mL = 6 mg/mL.
That rate is not acceptable. Vancomycin is a known irritant associated with infusion-related reactions (the flushing reaction, historically called red man syndrome) and phlebitis, and standard practice limits the rate to about 10 mg/min or 1 g per hour, whichever is slower. At 25 mg/min he is two and a half times over that limit.
Recalculate before starting:
- At 10 mg/min, 1,500 mg requires 150 minutes = 2.5 hours, which is 250 mL at 100 mL/hr.
- A common minimum is simply '1.5 g over 2 hours' (125 mL/hr, about 12.5 mg/min); 2.5 hours at 100 mL/hr is safer for a 52 kg patient.
Stop the pump, reprogram it, and document the rate change. Do not let a pre-programmed pump substitute for your own check.
2. Is the dose itself appropriate? Describe your reasoning and what you do before administering.
Read the worked answer
Weight-based check: 1,500 mg in a 52 kg patient is about 29 mg/kg per dose, above the usual 15-20 mg/kg for serious MRSA infection.
Renal function and levels: with an estimated creatinine clearance of 28 mL/min, vancomycin clearance is markedly reduced, so intervals must be extended. A pre-order level of 28 mcg/mL is far above the usual target (trough 10-15 mcg/mL, or an AUC24/MIC of 400-600), meaning he is already accumulating drug. Stacking 1,500 mg every 12 hours on top of that level predicts nephrotoxicity and ototoxicity - and his report of ringing in his ears raises the stakes considerably.
Action: do not administer as ordered. Clarify with the prescriber and pharmacy before giving the dose. A reasonable proposal is roughly 15 mg/kg (about 750-1,000 mg) with the interval extended to every 24 hours or longer and adjusted by levels, using AUC-guided monitoring where available. Confirm the timing of the 28 mcg/mL level, document his hearing complaint, and request audiology or at least serial symptom assessment if he continues on therapy. Document the clarification and the outcome in the record.
3. Assuming therapy continues, what monitoring and safety plan do you put in place?
Read the worked answer
Efficacy and toxicity monitoring:
- AUC-guided dosing with appropriately timed levels (or troughs before the fourth dose if AUC is unavailable), trending them rather than reacting to a single value.
- Renal function: serum creatinine and urine output at least every 1-2 days, daily weights, and strict intake and output. Note that he is at risk for acute kidney injury, which will further change dosing.
- Ototoxicity surveillance: ask about tinnitus, hearing change, and balance at every shift; consider audiometry.
Infusion safety:
- Infuse over at least 2-2.5 hours at roughly 10 mg/min, watching the first 15 minutes closely for flushing, pruritus, chest or back pain, and hypotension; stop and slow the rate if they occur and notify the provider.
- Assess the access site before, during, and after for phlebitis, and confirm the line is appropriate for a prolonged course; a peripheral site may not last for weeks of therapy.
Communication: make sure the clarified dose, interval, and rate are visible in the medication administration record and the handoff, since the original order and pump setting are the source of the error risk.